Start for free
Start for free
SM

SpringHill Management

Europe, Surrey, United Kingdom, Bramley

Description

SpringHill is a private equity fund management company specializing in early stage investments and development capital.

Investor Profile

SpringHill Management has made 5 investments, with 0 in the past 12 months and 40% as lead.

Stage Focus

  • Series F (40%)
  • Series C (40%)
  • Post Ipo Equity (20%)

Country Focus

  • China (60%)
  • United States (20%)
  • India (20%)

Industry Focus

  • Medical
  • Health Care
  • Pharmaceutical
  • Information Technology
  • Insurance
  • Insurtech
  • Mhealth
  • Biotechnology
  • Clinical Trials
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SpringHill Management frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
INCE Capital
INCE Capital
Asia, Shandong, China, Pudong
Co-Investments: 2
CITIC Securities
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
UOB Venture
UOB Venture
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
SC
Superstring Capital
North America, New York, United States, New York
Co-Investments: 2
Hel Ved Capital
Hel Ved Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
Rock Springs Capital
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
HongShan
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 2
B Capital
B Capital
North America, California, United States, Manhattan Beach
Co-Investments: 2
Kun Ling Capital
Kun Ling Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by SpringHill Management?

Miaoshou Doctor

Beijing, Beijing, China

Miaoshou Doctor is a health care platform that provides communication services between doctors and patients.

Health CareMedicalmHealth
Series FAug 4, 2021
Amount Raised: $231,971,916
Beijing Yuan Xin

Beijing, Beijing, China

Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.

Health CareInformation TechnologyInsuranceInsurTech
Series FAug 3, 2021
Amount Raised: $231,832,092
dMed

Shanghai, Shanghai, China

dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.

BiopharmaMedicalPharmaceutical
Series CJul 10, 2021
Amount Raised: $50,000,000
Clinipace

Morrisville, North Carolina, United States

Clinipace is a clinical research firm that offers integrated clinical research services for biopharmaceutical and medical firms.

BiotechnologyClinical TrialsMedical
Series CJul 8, 2021
Amount Raised: $50,000,000
Marksans Pharma

Mumbai, Maharashtra, India

Marksans Pharma is a pharmaceutical company that actively deals in R&D and offers CRAMS to healthcare companies.

Health CareMedicalPharmaceutical
Post Ipo EquityFeb 1, 2005
Amount Raised: $4,993,674
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator